Advanced Search

Chemical Pathology Stocks List

Symbol Grade Name % Change
MYGN A Myriad Genetics, Inc. 0.00
A A Agilent Technologies, Inc. 0.00
GBS F GBS Inc. 0.00
TNYA C Tenaya Therapeutics, Inc. 0.00
View As Page of Charts
Related Industries: Diagnostics & Research Medical Devices
Related Stock Lists: Biomarkers Biotechnology Clinical Medicine Diagnostic Tests Medicine Personalized Medicine Acid Analytical Chemistry Biology Biomarker Biosensor Blood Glucose Monitoring Breast And Ovarian Cancer Cancer Chromatography Colorectal Cancer Companion Diagnostic Diabetes Diabetes Management Diagnostic Services

Related ETFs - A few ETFs which own one or more of the above listed Chemical Pathology stocks.

Symbol Grade Name Weight
MJJ D MicroSectors Cannabis ETNs 9.9
MJO F MicroSectors Cannabis 2X Leveraged ETNs 9.9
GNOM B Global X Genomics & Biotechnology ETF 7.11
EDOC D Global X Telemedicine & Digital Health ETF 4.95
FIW A First Trust ISE Water Index Fund 4.31
View all Chemical Pathology ETFs...
Compare ETFs
  • Compare MJJ to GNOM
  • Compare MJO to FIW
  • Compare MJO to GNOM

    • Recent Signals

    Date Stock Signal Type
    2021-08-04 A New 52 Week High Strength
    2021-08-04 A Upper Bollinger Band Walk Strength
    2021-08-04 A New 52 Week Closing High Bullish
    2021-08-04 A Spinning Top Other
    2021-08-04 GBS Doji - Bullish? Reversal
    2021-08-04 MYGN Calm After Storm Range Contraction
    2021-08-04 MYGN Upper Bollinger Band Walk Strength
    2021-08-04 MYGN Shooting Star Candlestick Bearish
    2021-08-04 MYGN New 52 Week High Strength

    Chemical Pathology Stocks Recent News

    Date Stock Title
    Aug 4 A Agilent Earns 2021 Great Place to Work Certification in the U.S.
    Aug 4 MYGN Myriad Genetics (MYGN) Q2 Earnings Beat, Gross Margin Rises
    Aug 4 MYGN Are Investors Undervaluing Myriad Genetics, Inc. (NASDAQ:MYGN) By 33%?
    Aug 4 MYGN Myriad Genetics, inc (MYGN) Q2 2021 Earnings Call Transcript
    Aug 4 MYGN Myriad Genetics' (MYGN) CEO Paul Diaz on Q2 2021 Results - Earnings Call Transcript
    Aug 3 MYGN What's Up With Myriad Genetics Shares Trading Higher Tuesday?
    Aug 3 A TripAdvisor (TRIP) to Report Q2 Earnings: What's in Store?
    Aug 3 A AMETEK (AME) Q2 Earnings & Sales Beat Estimates, Rise Y/Y
    Aug 3 A Waters (WAT) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
    Aug 3 A Square (SQ) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
    Aug 3 A NXP Semiconductors (NXPI) Q2 Earnings Beat, Revenues Rise Y/Y
    Aug 3 A Expedia (EXPE) to Report Q2 Earnings: What's in the Offing?
    Aug 3 MYGN Myriad Genetics (MYGN) Beats Q2 Earnings and Revenue Estimates
    Aug 3 A Agilent Announces Target Enrichment Manufacturing Facility in China
    Aug 3 MYGN Myriad Genetics EPS beats by $0.22, beats on revenue
    Aug 3 MYGN Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
    Aug 3 MYGN Earnings Scheduled For August 3, 2021
    Aug 2 MYGN Myriad Genetics Q2 2021 Earnings Preview
    Aug 2 A Booking Holdings (BKNG) to Post Q2 Earnings: What's in Store?
    Aug 2 A Can Agilent (A) Keep the Earnings Surprise Streak Alive?
    Related Industries: Diagnostics & Research Medical Devices
    Related Stock Lists: Biomarkers Biotechnology Clinical Medicine Diagnostic Tests Medicine Personalized Medicine Acid Analytical Chemistry Biology Biomarker Biosensor Blood Glucose Monitoring Breast And Ovarian Cancer Cancer Chromatography Colorectal Cancer Companion Diagnostic Diabetes Diabetes Management Diagnostic Services

    Browse All Tags